Publications by authors named "Shinya Sakimoto"

Recent evidence suggests a role of transient receptor potential melastatin 2 (TRPM2) in immune and inflammatory responses. We previously reported that TRPM2 deficiency attenuated inflammatory and neuropathic pain in some pain mouse models, including formalin- or carrageenan-induced inflammatory pain, and peripheral nerve injury-induced neuropathic pain models, while it had no effect on the basal mechanical and thermal nociceptive sensitivities. In this study, we further explored the involvement of TRPM2 in various pain models using TRPM2-knockout mice.

View Article and Find Full Text PDF
Article Synopsis
  • * The study investigates how LPS and IFNγ activate microglia's signaling mechanisms, particularly focusing on calcium signaling and the role of the TRPM2 channel.
  • * Results indicate that the TRPM2 channel is crucial for the increased calcium signaling and subsequent activation of pathways that lead to elevated nitric oxide production when microglia are exposed to LPS/IFNγ.
View Article and Find Full Text PDF

Microglia are intrinsic immune cells in the brain. In response to neurodegenerative events, excessively activated microglia change their shapes and release various cytokines leading to the pathogenesis of central nervous system (CNS) disease. Because the intracellular mechanisms of this process are still unclear, we have evaluated the functional roles of transient receptor potential vanilloid 4 (TRPV4) channel expressed in the microglia.

View Article and Find Full Text PDF

Store-operated channels (SOC) are Ca(2+)-permeable channels that are activated by IP(3)-receptor-mediated Ca(2+) depletion of the endoplasmic reticulum (ER). Recent studies identify a membrane pore subunits, Orai1 and a Ca(2+) sensor on ER, STIM1 as components of Ca(2+) release-activated Ca(2+) (CRAC) channels, which are well-characterized SOCs. On the other hand, proteins that act as modulators of SOC activity remain to be identified.

View Article and Find Full Text PDF
Article Synopsis
  • Reactive astrogliosis is a response of astrocytes to CNS injuries like intracerebral hemorrhage, characterized by abnormal cell growth and shape.
  • Thrombin, released when the blood-brain barrier is compromised, triggers reactive astrogliosis by increasing TRPC3 protein levels in astrocytes, leading to heightened Ca(2+) influx and signaling pathways.
  • Inhibition of TRPC3 or Ca(2+) blockers can prevent astrocytic changes and proliferation induced by thrombin, suggesting TRPC3 plays a crucial role in astrocyte activation during brain injury.
View Article and Find Full Text PDF